Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Sales (2020 - 2025)

iSpecimen has reported Return on Sales over the past 6 years, most recently at 0.52% for Q4 2025.

  • For Q4 2025, Return on Sales fell 48.0% year-over-year to 0.52%; the TTM value through Dec 2025 reached 0.05%, down 3.0%, while the annual FY2025 figure was 0.05%, 3.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.52% at iSpecimen, down from 0.27% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q4 2021 and troughed at 0.52% in Q4 2025.
  • A 5-year average of 0.05% and a median of 0.01% in 2022 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: grew 1bps in 2021 and later tumbled -48bps in 2025.
  • Year by year, Return on Sales stood at 0.0% in 2021, then crashed by -6187bps to 0.01% in 2022, then plummeted by -51bps to 0.01% in 2023, then plummeted by -270bps to 0.04% in 2024, then crashed by -1178bps to 0.52% in 2025.
  • Business Quant data shows Return on Sales for ISPC at 0.52% in Q4 2025, 0.27% in Q3 2025, and 0.03% in Q2 2025.